Alzheimer’s remains one of the greatest medical mysteries — with no unified theory and current Aβ therapies facing safety challenges, the race for next-gen treatments is on.
Guess what? Taiwan is making serious moves!
6 Taiwanese biotech teams have already entered clinical trials, developing bold, novel mechanisms beyond the traditional Aβ focus. Could the next breakthrough come from here?
Meet the 6 trailblazers:

• Merry Life Biomedical (美力齡生醫)
• Elixiron Immunotherapeutics (安立璽榮)
• iBrainTX (中研院神經賦活)
• Vacino Biotech (法信諾生醫)
• B&V Biopharma (耀德生技)
• Botanicure (博太生醫)

Each is chasing new pathways — from neurorepair to inflammation modulation — aiming to become the next dark horse in global Alzheimer's innovation.
Dive into the full story:
https://news.gbimonthly.com/tw/magazine/article_show.php?num=75827
#AlzheimersResearch #TaiwanInnovation #Neurodegeneration #ClinicalTrials #FutureOfMedicine #Globalbio #BiotechNews #BrainHealth
Follow #Globalbio for more cutting-edge updates in biotech & pharmatech!